Your browser doesn't support javascript.
loading
Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Mulligan, Mark J; Lyke, Kirsten E; Kitchin, Nicholas; Absalon, Judith; Gurtman, Alejandra; Lockhart, Stephen; Neuzil, Kathleen; Raabe, Vanessa; Bailey, Ruth; Swanson, Kena A; Li, Ping; Koury, Kenneth; Kalina, Warren; Cooper, David; Fontes-Garfias, Camila; Shi, Pei-Yong; Türeci, Özlem; Tompkins, Kristin R; Walsh, Edward E; Frenck, Robert; Falsey, Ann R; Dormitzer, Philip R; Gruber, William C; Sahin, Ugur; Jansen, Kathrin U.
Afiliación
  • Mulligan MJ; New York University Langone Vaccine Center, New York, NY, USA.
  • Lyke KE; New York University Grossman School of Medicine, New York, NY, USA.
  • Kitchin N; University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, MD, USA.
  • Absalon J; Vaccine Research and Development, Pfizer Inc, Hurley, UK.
  • Gurtman A; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. judith.absalon@pfizer.com.
  • Lockhart S; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
  • Neuzil K; Vaccine Research and Development, Pfizer Inc, Hurley, UK.
  • Raabe V; University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore, MD, USA.
  • Bailey R; New York University Langone Vaccine Center, New York, NY, USA.
  • Swanson KA; New York University Grossman School of Medicine, New York, NY, USA.
  • Li P; Vaccine Research and Development, Pfizer Inc, Hurley, UK.
  • Koury K; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
  • Kalina W; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
  • Cooper D; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
  • Fontes-Garfias C; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
  • Shi PY; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
  • Türeci Ö; University of Texas Medical Branch, Galveston, TX, USA.
  • Tompkins KR; University of Texas Medical Branch, Galveston, TX, USA.
  • Walsh EE; BioNTech, Mainz, Germany.
  • Frenck R; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
  • Falsey AR; University of Rochester, Rochester, NY, USA.
  • Dormitzer PR; Rochester General Hospital, Rochester, NY, USA.
  • Gruber WC; Cincinnati Children's Hospital, Cincinnati, OH, USA.
  • Sahin U; University of Rochester, Rochester, NY, USA.
  • Jansen KU; Rochester General Hospital, Rochester, NY, USA.
Nature ; 590(7844): E26, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33469216
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Nature Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Nature Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos